Based on the limited information available on the role of βAR in breast cancer, particularly β1AR, it is premature to draw any conclusions of the pathophysiological significance GPR30-promoted inhibition of β1AR-stimulated cAMP production in this disorder. This evidence concerns the gene GPER1 and breast cancer.